Overweight and obesity: An overview of prevalence, clinical impact, and economic impact

Disease Management

Volumn 7, Issue SUPPL. 1, 2004, Pages

  Friedman, Neal ^a   Fanning, Etta L ^b  

^a S Ctrl Preferred/WellSpan Hlth   (United States)

^b Sanofi Synthelabo   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGED; ANGINA PECTORIS; BLADDER DYSFUNCTION; CANCER; CARDIOVASCULAR DISEASE; CHOLECYSTITIS; CHOLELITHIASIS; COMORBIDITY; CONGESTIVE HEART FAILURE; DYSLIPIDEMIA; ETHNIC DIFFERENCE; EUROPE; FEMALE; GALLSTONE; GLUCOSE INTOLERANCE; GOUT; GROUPS BY AGE; HEALTH SURVEY; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; PREGNANCY COMPLICATION; PREVALENCE; RACE DIFFERENCE; REPRODUCTIVE HEALTH; REVIEW; SLEEP APNEA SYNDROME; SOCIOECONOMICS; STROKE; UNITED STATES;

EID: 6344225832     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2004.7.s-1     Document Type: Review

References (45)

1. National Research Council. Committee on Diet and Health. Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press, 1989.
2. Forster JL, Jeffery RW, Schmid TL, et al. Preventing weight gain in adults: a pound of prevention. Health Psychol 1988;7:515-525.
3. National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Washington, DC: NHLBI, 1998.
4. Vastag B. Obesity is now on everyone's plate. JAMA 2004;291:1186.
5. American Obesity Association. www.AOA.org.
6. 1999-2000 National Health and Nutrition Examination Survey (NHANES).
7. Health, United States, 2002, table 71 Overweight children and adolescents 6-19 years of age, according to sex, age, race, and Hispanic origin: United States, selected years 1963-65 through 1999-2000.
8. Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among U.S. children and adolescents, 1999-2000. JAMA 2002;288:1728-1732.
9. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;10:1195-1200.
10. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: DHHS, NIH, NHLBI, 1998.
11. Comuzzie AG, Mitchell BD, Cole S, et al. The genetics of obesity in Mexican Americans: the evidence from genome scanning efforts in the San Antonio Family Heart Study. Hum Biol 2003;75:635-646.
12. Centers for Disease Control and Prevention, Division of Diabetes Translation, The CDC DDT Public Health Resource Page. Available: www.cdc.gov/diabetes/index.htm.
13. Mokdad AH, Serdula M, Dietz W, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-1522.
14. Modkad AH, Serdula M, Dietz W, et al. The continuing obesity epidemic in the United States. JAMA 2000;284:1650-1651.
15. Mokdad AH, Bowman BA, Ford ES, et al. Prevelance of obesity, diabetes, and obesity related health risk factors. JAMA 2003;289:76-79.
16. Stunkard AJ, Wadden TA, eds. Obesity: theory and therapy, 2nd ed. New York: Raven Press, 1993.
17. Minino AM, Arias E, Kochanek KD, et al. Deaths: final data for 2000. National Vital Statistics Reports 2002;50:1-120.
18. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-1246.
19. Mokdad AH, Bowman BA, Ford ES, et al. Prevalence of obesity, diabetes, and obesity related health risk factors. JAMA 2003;289:76-79.
20. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA 2004;289:1813-1819.
21. Department of Pediatrics, Yale University School of Medicine. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362:951-957.
22. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
23. Trevisan M, Liu J, Bahsas FB, et al. Syndrome X and mortality: a population-based study: Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998;148:958-966.
24. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
25. Sowers JR. Obesity as a cardiovascular risk factor. AJM 2003;115:37S-41S.
26. Centers for Disease Control and Prevention (CDC). Declining prevalence of no known major risk factors for heart disease and stroke among adults-United States, 1991-2001. MMWR. 2004;53:4-7.
27. Centers for Disease Control and Prevention, Division of Diabetes Translation, The CDC DDT Public Health Resource Page. Available: www.cdc.gov/diabetes/index.htm.
28. American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003;26:917-923.
29. American Heart Association. 2001 Heart and Stroke Statistical Up-date.
30. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the National Cholestrol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
31. Pearson TA, Laurora I, Chu H, et al. The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459-467.
32. Anonomous. Obesity causes nearly 100,000 cancer deaths per year. N Engl J Med 2003;348:1625-1638.
33. Fontaine KR, Bartlett SJ. Access and use of medical care among obese persons. Obesity Res 2000;8:403-406.
34. United States Department of Health and Human Services, 2001.
35. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obesity Res 1998;6:97-106.
36. Wolf A. What is the economic case for treating obesity? Obesity Res 1998;6:2S-7S.
37. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Affairs 2003;W3:219-226.
38. Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obesity Res 2004;12:18-24.
39. Quesenberry CP, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998;158:466-472.
40. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6:97-106.
41. Committee on the Consequences of Uninsurance, Board of Health Care Services, Institute of Medicine. Health insurance is a family matter. Washington, DC: National Academies Press, 2002.
42. Oster G, Edelsbert J, O'Sullivan AK, et al. The clinical and economic burden of obesity in a managed care setting. Am J Managed Care 2000;6:681-689.
43. Livingston EH, Ko CY. Socioeconomic characteristics of the population eligible for obesity surgery. Surgery 2004;135:288-296.
44. Koplan JB. Centers for Disease Control and Prevention, February 2002.
45. Chronic disease prevention fact sheet: actual causes of death in the united states. Available: www.cdc.gov, 2000.